Top Story

Bivalent HPV vaccine immunogenic, safe

August 20, 2014

The HPV-16/18 AS04-adjuvanted vaccine demonstrated efficacy and immunogenicity without any safety concerns, according to recent study results published in Human Vaccines and Immunotherapeutics.

The study was a follow-up of a double blind, randomized, placebo-controlled trial (HPV-001). Researchers assessed the efficacy of a bivalent HPV-16/18 vaccine (Cervarix, GlaxoSmithKline) in a subset of 437 women from the original study enrolled at five Brazilian centers. Participants were aged 15 to 25 years, and had previously been assigned vaccination or placebo. For the current study (HPV-023), researchers followed participants for more than 9 years, taking annual measurements of anti-HPV-16/18 antibodies.

In the Journals

No benefit seen with IV peramivir in hospitalized patients with influenza

August 20, 2014
Treatment with the IV antiviral peramivir did not demonstrate a significant clinical benefit compared with placebo among patients hospitalized with suspected influenza…
figure Industry News

World Hepatitis Alliance launches HCV Quest

August 19, 2014
The World Hepatitis Alliance has created HCV Quest, a global survey that provides a forum for patients with hepatitis C virus, according to an announcement on the…
In the Journals

Rifamycin regimens most effective against latent TB

August 19, 2014
In patients with latent tuberculosis infection, treatment regimens that included at least 3 months of rifamycin were most effective at preventing active disease…
More News Headlines »
Cover Stories Perspective

Progress on the horizon to implement ‘lifelong’ immunization registries

Infectious Disease News, July 2014
Immunization registries are an important public health tool. Besides serving as a way for health care providers to…
More »
Blog

Updates to adult immunization schedule

January 30, 2013
Each year in January, the CDC publishes an adult immunization schedule, updating information relating to the vaccines…
More »
Video
figure

Gene surgery effectively removes HIV-1 from human cells

July 29, 2014
PHILADELPHIA — Temple University researchers have successfully eradicated latent HIV-1 virus from cultured human…
More »